Description
PT-141 Research Peptide | Bremelanotide Cyclic Peptide
PT-141 Research Peptide is a synthetic cyclic heptapeptide featuring a defined amino-acid sequence and a cyclic peptide structure. It is also associated with the research name bremelanotide. The reported molecular formula is C₅₀H₆₈N₁₄O₁₀, with a molecular weight of approximately 1,025.2 g/mol.
At LV Longevity Peptides, PT-141 is positioned as a specialized research material for controlled laboratory and analytical applications involving cyclic peptide structure, molecular interactions, stability, and peptide behavior under defined experimental conditions.
This product version is supplied as a pre-formulated aqueous research solution, rather than a conventional lyophilized powder. Because it is a finished liquid formulation, the product page should emphasize compound identity, labeled content, formulation volume, and batch-specific assay information.
PT-141 Research Peptide Sequence
The reported PT-141 sequence is:
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
The notation indicates an N-acetylated cyclic peptide containing a norleucine residue and a defined cyclic structure. The cyclic configuration is an important part of PT-141’s chemical identity and should be retained in technical product documentation.
141 Research Applications
PT-141 may be investigated in controlled laboratory environments for:
Cyclic peptide structure and sequence characterization
Peptide–receptor interaction studies
Melanocortin-related biochemical research
Molecular signaling pathway analysis
Structure–activity relationship investigations
Peptide stability and degradation studies
Analytical method development
Comparative research involving synthetic cyclic peptides
These descriptions refer to non-clinical laboratory research only and should not be interpreted as claims of medical efficacy or consumer use.
PT-141 and Bremelanotide
PT-141 is commonly associated with bremelanotide, a synthetic cyclic peptide compound. However, an LV research material should not be represented as an approved pharmaceutical product or as a substitute for any prescription medication.
The LV product page should clearly distinguish the research compound from regulated pharmaceutical products and should maintain a strict research-use-only position.
Technical Specifications
Specification | PT-141 |
|---|---|
Product Name | PT-141 |
Product Type | Synthetic research peptide |
Peptide Class | Cyclic heptapeptide |
Associated Name | Bremelanotide |
Chemical Formula | C₅₀H₆₈N₁₄O₁₀ |
Molecular Weight | Approximately 1,025.2 g/mol |
Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
Physical Form | Aqueous solution |
Chemical Information:
- Chemical Name: PT-141
- Molecular Formula: C50H68N14O10
- Molecular Weight: 1025.2 g/mol
- Sequence: Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH
Molecular Structure:
